Pharmaceutical approval update…

Related Articles
Pharmaceutical approval update. P T. 2014 Aug;39(8):553-66 Authors: Goldenberg MM Abstract Vedolizumab (Entyvio) for ulcerative colitis and Crohn's disease; dalbavancin (Dalvance) for acute bacterial skin and skin structure infections; and antihemophilic factor, recombinant (Eloctate) for hemophilia A. PMID: 25136251 [PubMed]